Strong House Vote On PBM, Generics Bill Sets Stage For Early 2024 Action

Easy House passage of a health package that includes PBM reforms and policies to help generic drug makers likely creates enough momentum to spur bicameral action. Overall policy still a work in progress – presenting last-minute opportunities for other drug pricing reforms to get tacked on.

US Capitol building
The House of Representatives easily cleared a PBM reform bill on 11 December. • Source: Shutterstock

The US House of Representatives easily cleared a health care package that includes pharmacy benefit management reform and measures to help generic drug companies on 11 December, giving the policy goals a necessary momentum boost needed to help them hitch a ride on the government funding bill lawmakers will need to pass by 19 January 2024 to keep certain parts of the government open.

A Senate Finance Committee spokesperson told the Pink Sheet not to expect any Senate action on the topic before the...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legislation

More from Pink Sheet